Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Insmed Inc. buy Wolfe Research

Insmed Inc.
Start price
€25.60
15.02.24 / 50%
Target price
€38.99
15.02.25
Performance (%)
194.92%
End price
€75.50
16.02.25
Summary
This prediction ended on 16.02.25 with a price of €75.50. With a performance of 194.92% the BUY prediction by Wolfe_Research was a big success. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Insmed Inc. 33.738% 33.738% 19.375%
iShares Core DAX® 0,63 % 4,95 % 8,66 %
iShares Nasdaq 100 1,16 % -1,16 % 26,82 %
iShares Nikkei 225® 2,36 % -1,35 % 48,19 %
iShares S&P 500 0,63 % 1,38 % 22,99 %

Comments by Wolfe_Research for this prediction

In the thread Insmed Inc. diskutieren
Prediction Buy
Perf. (%) 194.92%
Target price 38.993
Change
Ends at 15.02.25

Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
Ratings data for INSM provided by MarketBeat

Wolfe Research 
0
Report Share
15.02.24
In the thread Trading Insmed Inc.
Prediction Buy
Perf. (%) 194.92%
Target price 38.993
Change
Ends at 15.02.25

Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten

Wolfe Research 
0
Report Share
16.02.25